What is the best medicine to treat patent ductus arteriosus?

What is the best medicine for treating patent ductus arteriosus? The occurrence of patent ductus arteriosus really brings too much harm to our patients. If patent ductus arteriosus occurs, we should not ignore the treatment. We should take timely and correct treatment measures. This is the key to effective recovery from the disease. So, what is the best medicine for treating patent ductus arteriosus? Let's learn about it together.

Drug treatment for patent ductus arteriosus is mainly used to treat complications such as respiratory tract infection, heart failure, and endocarditis. If the baby has shortness of breath or heart failure after birth, the patient can first control the amount of fluid, assist breathing, and receive diuretics (furosemide 1 mg/kg intravenous injection) and cardiotonic (cedilanid 0.01-0.015 mg/kg intravenous injection) to improve cardiopulmonary function, and blood transfusion to correct anemia. Usually, the probability of premature infants suffering from patent ductus arteriosus is very high. Therefore, for premature infants with low weight (less than 1500g), the increase in blood oxygen content can promote the contraction and closure of the large ductus arteriosus, reducing or eliminating the shunt from the autonomic artery to the pulmonary artery. Respiratory tract infection requires antibiotic therapy. Endocarditis is treated with large doses of drug-sensitive antibiotics. If it cannot be controlled, surgery should be performed instead.

Patent ductus arteriosus in premature infants can usually close naturally after birth when they reach mature age, so asymptomatic infants do not need to be treated. If symptoms occur, treatment with the prostaglandin synthetase inhibitor indomethacin can be tried, 0.2MG/KG each time, orally, by enema or intravenous injection. If ineffective, it can be repeated 1 to 2 times every 8 hours, and the total amount should not exceed 0.6MG/KG. It is contraindicated in patients with poor renal function, serum creatinine 132.6UMOL/L (1.5MG/DL), or urea nitrogen 7.1MMOL/L (20MG/DL), bleeding tendency, platelet count 50×109/L, or suspected necrotizing enterocolitis.

After introducing so much to you, I believe that parents have a better understanding and grasp of the treatment of patent ductus arteriosus in newborns. After the treatment of this disease, active preventive measures must be taken to avoid infection and aggravation of the condition. In life, children should maintain a good attitude and follow the doctor's medication.